Use of extracorporeal photopheresis in scleroderma: a review
AX Du, M Osman, R Gniadecki - Dermatology, 2020 - karger.com
Background: Scleroderma is a heterogeneous group of diseases that can be localized or
systemic. Localized scleroderma is a fibrosis of the skin characterized by inflammation and …
systemic. Localized scleroderma is a fibrosis of the skin characterized by inflammation and …
Management of severe scleroderma with long-term extracorporeal photopheresis
K Krasagakis, E Dippel, J Ramaker, M Owsianowski… - Dermatology, 1998 - karger.com
Background: The management of systemic sclerosis remains unsatisfactory. Thus far, the
action of extracorporeal photopheresis (ECP) in severe systemic scleroderma has been …
action of extracorporeal photopheresis (ECP) in severe systemic scleroderma has been …
Extracorporeal photopheresis for systemic sclerosis: A meta‐analysis of randomized clinical trials
C Delbrück, T Gambichler, L Susok… - Dermatologic …, 2022 - Wiley Online Library
Abstract Systemic sclerosis (scleroderma)(SSc) is a rare autoimmune disorder characterized
by excessive production of collagen. Extracorporeal photopheresis (photochemotherapy …
by excessive production of collagen. Extracorporeal photopheresis (photochemotherapy …
A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
RM Knobler, LE French, Y Kim, E Bisaccia… - Journal of the American …, 2006 - Elsevier
BACKGROUND: Systemic sclerosis is a multisystemic connective tissue disease with
marked involvement of the skin and joints for which few effective evidence based therapies …
marked involvement of the skin and joints for which few effective evidence based therapies …
Photopheresis: advances and use in systemic sclerosis
Abstract Purpose of Review Extracorporeal photochemotherapy (photopheresis, ECP) is a
cell-based immunomodulatory treatment that separates leukocytes from peripheral blood …
cell-based immunomodulatory treatment that separates leukocytes from peripheral blood …
Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis)
DNH Enomoto, JR Mekkes, PMM Bossuyt… - Journal of the American …, 1999 - Elsevier
Background: Effective treatment modalities for systemic sclerosis, a life-threatening and
disabling disease, are still lacking. Possible efficacy of photopheresis has been reported in …
disabling disease, are still lacking. Possible efficacy of photopheresis has been reported in …
Extracorporeal photochemotherapy in systemic sclerosis and severe morphea
B Cribier, T Faradji, C Le Coz, F Oberling, E Grosshans - Dermatology, 1995 - karger.com
Background: Extracorporeal photochemotherapy (EP) is a new immune-modulating therapy
which combines cytapheresis and extracorporeal irradiation of leukocytes by UVA. Recently …
which combines cytapheresis and extracorporeal irradiation of leukocytes by UVA. Recently …
Extracorporeal photochemotherapy in progressive systemic sclerosis: a follow‐up study
J Schwartz, J Gonzalez, M Palangio… - International journal …, 1997 - Wiley Online Library
Background Extracorporeal photochemotherapy (photopheresis), an immune‐modulating
therapy, has been demonstrated to elicit a therapeutic response in the treatment of several …
therapy, has been demonstrated to elicit a therapeutic response in the treatment of several …
[HTML][HTML] Phototherapy in scleroderma
J Hassani, SR Feldman - Dermatology and Therapy, 2016 - Springer
Systemic and localized scleroderma are difficult to manage diseases with no accepted gold
standard of therapy to date. Phototherapeutic modalities for scleroderma show promise. A …
standard of therapy to date. Phototherapeutic modalities for scleroderma show promise. A …
Preliminary results on long-term follow-up of systemic sclerosis patients under extracorporeal photopheresis
T Gambichler, O Özsoy, D Bui, CH Scheel… - Journal of …, 2022 - Taylor & Francis
Background Extracorporeal photopheresis (ECP) has been considered for treatment of
patients with systemic sclerosis (SSc). Objectives To study the 12-month effects of ECP on …
patients with systemic sclerosis (SSc). Objectives To study the 12-month effects of ECP on …